SNM vs botulinum toxin A in OAB: cost effectiveness debated

Author：

ISSN： 1173-5503

Source： PharmacoEconomics and Outcomes News, Vol.1, Iss.578, 2009-01, pp. : 8-8

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Cost effectiveness of ixabepilone debated

PharmacoEconomics and Outcomes News, Vol. 1, Iss. 576, 2009-01 ,pp. : 9-9

Adis International

Access to resources Recommend Favorite

Cost effectiveness of lung cancer screening debated

PharmacoEconomics and Outcomes News, Vol. 1, Iss. 413, 2003-01 ,pp. : 2-2

Adis International

Access to resources Recommend Favorite

CT screening for lung cancer - cost effectiveness debated

PharmacoEconomics and Outcomes News, Vol. 1, Iss. 591, 2009-01 ,pp. : 11-11

Adis International

Access to resources Recommend Favorite

Rofecoxib cost-effectiveness study results debated

PharmacoEconomics and Outcomes News, Vol. 1, Iss. 455, 2004-01 ,pp. : 2-2

Adis International

Access to resources Recommend Favorite

Botulinum toxin A cost effective for urinary incontinence in France . . .

PharmacoEconomics and Outcomes News, Vol. 1, Iss. 612, 2010-01 ,pp. : 5-5

Adis International

Access to resources Recommend Favorite